Florida; Tax Secured, General Obligation Sep 01

  • ID: 1751178
  • September 2001
  • Region: Florida
  • Standard & Poors
1 of 3

Florida's state board of education public education capital outlay refunding bonds 2001 series E are ultimately secured by the state's full faith and credit pledge. Debt service is payable in the first instance from a second-lien pledge on gross receipts tax revenues collected from providers of electric, natural gas, and telecommunications industries operating in the state. The taxes are constitutionally dedicated to pay debt service. Gross receipts tax revenues of $723 million in fiscal 2001 covered annual program debt service of $554.8 million by 1.3 times (x). Gross receipts tax collections have experienced steady annual growth in the past decade; average annual growth from 1997-2001 was a healthy 5.9%. The Florida Consensus Revenue Estimating Conference (REC) does long-term projections of...

Companies mentioned in this report are:
- Florida

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3


Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our


Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.